Liu Ouyang
Shanghai, 200434, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Identification of blood-derived exosomal tumor RNA signatures as noninvasive diagnostic biomarkers for multi-cancer: a multi-phase, multi-center study.
Journal: Molecular cancer
Published: January 20, 2025
Pumilio RNA binding family member 1 deficiency activates anti-tumor immunity in hepatocellular carcinoma via restraining M2 macrophage polarization.
Journal: Cell cycle (Georgetown, Tex.)
Published: May 25, 2024
LncRNA FOXD1-AS1 regulates pancreatic cancer stem cell properties and 5-FU resistance by regulating the miR-570-3p/SPP1 axis as a ceRNA.
Journal: Cancer cell international
Published: September 03, 2023
Early oral feeding versus nasojejunal early enteral nutrition in patients following pancreaticoduodenectomy: a propensity score-weighted analysis of 428 consecutive patients.
Journal: International journal of surgery (London, England)
Published: June 17, 2023
Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell-mediated antitumor activity.
Journal: Frontiers in immunology
Published: November 09, 2022
Nomogram predicts CR-POPF in open central pancreatectomy patients with benign or low-grade malignant pancreatic neoplasms.
Journal: Frontiers in oncology
Published: August 28, 2022
Low CPEB1 levels may predict the benefit of 5-fluorouracil treatment in patients with colon or stomach adenocarcinoma.
Journal: Journal of gastrointestinal oncology
Published: June 02, 2022
UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation.
Journal: Journal of gastrointestinal oncology
Published: May 13, 2022
Incidence of bifid pancreatic duct in pancreaticoduodenectomy and its impact on clinically relevant postoperative pancreatic fistula.
Journal: Frontiers in oncology
Published: May 03, 2022
Decreased Expression of Programmed Death Ligand-L1 by Seven in Absentia Homolog 2 in Cholangiocarcinoma Enhances T-Cell-Mediated Antitumor Activity.
Journal: Frontiers in immunology
Published: December 29, 2021
Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis.
Journal: Annals of translational medicine
Published: December 22, 2021
MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer.
Journal: Annals of translational medicine
Published: November 24, 2021
Last Updated: 09/26/2026